Stanley S Schwartz, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 233 E Lancaster Ave, Suite 305, Ardmore, PA 19003 Phone: 610-642-6800 Fax: 610-642-6850 |
News Archive
Duke Researchers have pinpointed a new therapeutic target for macular degeneration, an eye disease that affects over 10 million Americans and is the leading cause of blindness in adults over 60.
The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.
Abbott announced today that it has introduced the PLEX-ID Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens.
Today (Thursday 26 August) the government launches its back to school and college campaign to set out the experience that students can 'get back to' from September, with restrictions such as bubbles eased to allow a full return to sport, music, drama, science experiments and being with their friends.
› Verified 7 days ago